Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$6.8 - $8.01 $3.17 Million - $3.74 Million
466,712 New
466,712 $3.23 Million
Q2 2022

Aug 15, 2022

SELL
$6.85 - $8.87 $3.2 Million - $4.14 Million
-466,712 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$6.3 - $10.86 $924,228 - $1.59 Million
146,703 Added 45.84%
466,712 $3.86 Million
Q3 2021

Nov 15, 2021

BUY
$9.63 - $12.47 $3.08 Million - $3.99 Million
320,009 New
320,009 $3.86 Million
Q2 2021

Aug 16, 2021

SELL
$10.9 - $14.29 $2.89 Million - $3.79 Million
-265,346 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$12.22 - $14.16 $76,717 - $88,896
-6,278 Reduced 2.31%
265,346 $3.76 Million
Q3 2020

Nov 13, 2020

BUY
$10.8 - $13.5 $2.93 Million - $3.67 Million
271,624 New
271,624 $3.34 Million

Others Institutions Holding AMYT

About Amryt Pharma plc


  • Ticker AMYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 64,177,000
  • Description
  • Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...
More about AMYT
Track This Portfolio

Track Whitebox Advisors LLC Portfolio

Follow Whitebox Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whitebox Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Whitebox Advisors LLC with notifications on news.